Program
|
Deadline
|
Description
|
| AstraZeneca Preclinical Molecules |
Rolling Admissions
|
Identifying disease targets for active molecules is integral to modern drug discovery. AstraZeneca's aim is to make high-quality life science research tools available to the external research community to accelerate innovative scientific research. These include antibodies, PROTAC molecules and oligonucleotides that have been developed as part of its drug discovery programs. By combining AstraZeneca's resources with your insights, we can generate high-quality preclinical data that enhances the understanding of disease pathways and supports the future generation of life-changing medicines. |
| Merck Business Development |
Rolling Admissions |
Multiple opportunities. Please refer to website for details. |
| AstraZeneca open innovations |
Rolling Admissions |
Multiple opportunities. Please refer to website for details. |
| Rare Treatment Accelerator (RTA) |
Rolling Admissions |
The Rare Treatment Accelerator program connects academic groups, patient groups and early-stage biotechs with Healx to unlock the power of repurposed drugs for rare diseases. Working together, we can quickly turn your research, insights and promising repurposing assets into treatments that will benefit rare disease patients. |
| Pfizer-Vaccines Areas of Interest |
Rolling Admissions |
Qualified researchers are invited to submit research proposals, according to the guidance and instructions found on www.pfizer.com/ISR. A proposal requesting Pfizer support (e.g., funding and/or drug supply) is not a guarantee of acceptance or approval of that proposal. Decisions on support for submissions are made by the applicable Pfizer Global Reviewers. |
| Pfizer- Inflammation and Immunology Areas of Interest |
Rolling Admissions |
Qualified researchers are invited to submit research proposals, according to the guidance and instructions found on www.pfizer.com/ISR. A proposal requesting Pfizer support (e.g., funding and/or drug supply) is not a guarantee of acceptance or approval of that proposal. Decisions on support for submissions are made by the applicable Pfizer Global Reviewers. |
| Pfizer- Rare Disease Areas of Interest |
Rolling Admissions |
Qualified researchers are invited to submit research proposals, according to the guidance and instructions found on www.pfizer.com/ISR. A proposal requesting Pfizer support (e.g., funding and/or drug supply) is not a guarantee of acceptance or approval of that proposal. Decisions on support for submissions are made by the applicable Pfizer Global Reviewers. |
| Pfizer- Internal Medicine Areas of Interest |
Rolling Admissions |
Qualified researchers are invited to submit research proposals, according to the guidance and instructions found on www.pfizer.com/ISR. A proposal requesting Pfizer support (e.g., funding and/or drug supply) is not a guarantee of acceptance or approval of that proposal. Decisions on support for submissions are made by the applicable Pfizer Global Reviewers. |
